Overview

Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury

Status:
Completed
Trial end date:
2017-07-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
United States Department of Defense
Treatments:
Tranexamic Acid